+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Anti-infective external coating of central venous catheters: a randomized, noninferiority trial comparing 5-fluorouracil with chlorhexidine/silver sulfadiazine in preventing catheter colonization



Anti-infective external coating of central venous catheters: a randomized, noninferiority trial comparing 5-fluorouracil with chlorhexidine/silver sulfadiazine in preventing catheter colonization



Critical Care Medicine 38(11): 2095-2102



The antimetabolite drug, 5-fluorouracil, inhibits microbial growth. Coating of central venous catheters with 5-fluorouracil may reduce the risk of catheter infection. Our objective was to compare the safety and efficacy of central venous catheters externally coated with 5-fluorouracil with those coated with chlorhexidine and silver sulfadiazine. Prospective, single-blind, randomized, active-controlled, multicentered, noninferiority trial. Twenty-five US medical center intensive care units. A total of 960 adult patients requiring central venous catheterization for up to 28 days. Patients were randomized to receive a central venous catheter externally coated with either 5-fluorouracil (n = 480) or chlorhexidine and silver sulfadiazine (n = 480). The primary antimicrobial outcome was a dichotomous measure (<15 colony-forming units or ≥ 15 colony-forming units) for catheter colonization determined by the roll plate method. Secondary antimicrobial outcomes included local site infection and catheter-related bloodstream infection. Central venous catheters coated with 5-fluorouracil were noninferior to chlorhexidine and silver sulfadiazine coated central venous catheters with respect to the incidence of catheter colonization (2.9% vs. 5.3%, respectively). Local site infection occurred in 1.4% of the 5-fluorouracil group and 0.9% of the chlorhexidine and silver sulfadiazine group. No episode of catheter-related bloodstream infection occurred in the 5-fluorouracil group, whereas two episodes were noted in the chlorhexidine and silver sulfadiazine group. Only Gram-positive organisms were cultured from 5-fluorouracil catheters, whereas Gram-positive bacteria, Gram-negative bacteria, and Candida were cultured from the chlorhexidine and silver sulfadiazine central venous catheters. Adverse events were comparable between the two central venous catheter coatings. Our results suggest that central venous catheters externally coated with 5-fluorouracil are a safe and effective alternative to catheters externally coated with chlorhexidine and silver sulfadiazine when used in critically ill patients.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051568226

Download citation: RISBibTeXText

PMID: 20711070

DOI: 10.1097/ccm.0b013e3181f265ba


Related references

A Comparison Of The Time To Catheter Colonization (Cc) And Catheter Related Bloodstream Infection (Crbsi) Between Central Venous Catheters (Cvc) Coated With Either 5-Fluorouracil (5-Fu) Or Chlorhexidine/Silver Sulfadiazine (Ch-Ss). Chest 134(4): s3002-a-s3002-b, 2008

Effect of chlorhexidine/silver sulfadiazine coating on microbial colonization of central venous catheters in a multicenter trial. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 439, 2001

Chlorhexidine and silver sulfadiazine coating on central venous catheters is not sufficient for protection against catheter-related infection: Simulation-based laboratory research with clinical validation. Journal of International Medical Research 45(3): 1042-1053, 2017

Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Annals of Internal Medicine 143(8): 570-580, 2005

Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter. Annals of Hematology 84(4): 258-262, 2005

Reduction of central venous catheter-related infection in cancer patients with severe neutropenia A prospective controlled randomized trial using a chlorhexidine and silver-sulfadiazine impregnated central venous line. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 447, 2001

Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Trial. Journal of the American College of Surgeons 221(3): 739-747, 2015

Evaluation of a triple-lumen central venous catheter heparin-bonded versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients A randomized, clinical trial. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 426, 2001

Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. Journal of Hospital Infection 37(2): 145-156, 1997

Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria. Journal of Clinical Microbiology 34(10): 2640-2641, 1996

Prevention of colonization of central venous catheters by silver-sulfadiazine-chlorhexidine bonding A pilot study in critical care patients. Anesthesiology 79(3A): A294, 1993

Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Archives of Internal Medicine 158(1): 81-87, 1998

Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial. Intensive Care Medicine 30(5): 837-843, 2004

Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients--a double-blind, randomised, prospective, controlled trial. Supportive Care in Cancer 13(12): 993, 2005

Efficacy of silver iontophoretic central venous catheters in preventing catheter-related bloodstream infection amongst high-risk patients A randomized controlled trial. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 426, 2001